308 related articles for article (PubMed ID: 24565764)
1. Indications, protocols, and outcomes of drug desensitizations for chemotherapy and monoclonal antibodies in adults and children.
Hong DI; Dioun AF
J Allergy Clin Immunol Pract; 2014; 2(1):13-9; quiz 20. PubMed ID: 24565764
[TBL] [Abstract][Full Text] [Related]
2. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.
Wong JT; Ling M; Patil S; Banerji A; Long A
J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767
[TBL] [Abstract][Full Text] [Related]
3. Rapid desensitization for hypersensitivity reactions to chemotherapy agents.
Castells M
Curr Opin Allergy Clin Immunol; 2006 Aug; 6(4):271-7. PubMed ID: 16825867
[TBL] [Abstract][Full Text] [Related]
4. Drug desensitization in the management of hypersensitivity reactions to monoclonal antibodies and chemotherapy.
Mezzano V; Giavina-Bianchi P; Picard M; Caiado J; Castells M
BioDrugs; 2014 Apr; 28(2):133-44. PubMed ID: 23990250
[TBL] [Abstract][Full Text] [Related]
5. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases.
Castells MC; Tennant NM; Sloane DE; Hsu FI; Barrett NA; Hong DI; Laidlaw TM; Legere HJ; Nallamshetty SN; Palis RI; Rao JJ; Berlin ST; Campos SM; Matulonis UA
J Allergy Clin Immunol; 2008 Sep; 122(3):574-80. PubMed ID: 18502492
[TBL] [Abstract][Full Text] [Related]
6. Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment.
Madrigal-Burgaleta R; Berges-Gimeno MP; Angel-Pereira D; Ferreiro-Monteagudo R; Guillen-Ponce C; Pueyo C; Gomez de Salazar E; Alvarez-Cuesta E
Allergy; 2013 Jul; 68(7):853-61. PubMed ID: 23647576
[TBL] [Abstract][Full Text] [Related]
7. Drug Hypersensitivity and Desensitizations.
Castells MC
Immunol Allergy Clin North Am; 2017 Nov; 37(4):xvii-xviii. PubMed ID: 28965644
[No Abstract] [Full Text] [Related]
8. Desensitization to chemotherapeutic agents.
Lieberman P; Castells M
J Allergy Clin Immunol Pract; 2014; 2(1):116-7. PubMed ID: 24565784
[No Abstract] [Full Text] [Related]
9. Rapid drug desensitization for hypersensitivity reactions to chemotherapy and monoclonal antibodies in the 21st century.
Castells Guitart MC
J Investig Allergol Clin Immunol; 2014; 24(2):72-9; quiz 2 p following 79. PubMed ID: 24834769
[TBL] [Abstract][Full Text] [Related]
10. Allergy to monoclonal antibodies: cutting-edge desensitization methods for cutting-edge therapies.
Hong DI; Bankova L; Cahill KN; Kyin T; Castells MC
Expert Rev Clin Immunol; 2012 Jan; 8(1):43-52; quiz 53-4. PubMed ID: 22149339
[TBL] [Abstract][Full Text] [Related]
11. Desensitization regimens for drug allergy: state of the art in the 21st century.
Liu A; Fanning L; Chong H; Fernandez J; Sloane D; Sancho-Serra M; Castells M
Clin Exp Allergy; 2011 Dec; 41(12):1679-89. PubMed ID: 21883538
[TBL] [Abstract][Full Text] [Related]
12. Desensitization for hypersensitivity reactions to medications.
del Carmen Sancho M; Breslow R; Sloane D; Castells M
Chem Immunol Allergy; 2012; 97():217-33. PubMed ID: 22613865
[TBL] [Abstract][Full Text] [Related]
13. A desensitization protocol for the mAb cetuximab.
Jerath MR; Kwan M; Kannarkat M; Mirakhur B; Carey L; Valgus J; Platts-Mills TA; Tarrant TK
J Allergy Clin Immunol; 2009 Jan; 123(1):260-2. PubMed ID: 19022494
[No Abstract] [Full Text] [Related]
14. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment.
Brennan PJ; Rodriguez Bouza T; Hsu FI; Sloane DE; Castells MC
J Allergy Clin Immunol; 2009 Dec; 124(6):1259-66. PubMed ID: 19910036
[TBL] [Abstract][Full Text] [Related]
15. Desensitizations for chemotherapy and monoclonal antibodies: indications and outcomes.
Hsu Blatman KS; Castells MC
Curr Allergy Asthma Rep; 2014 Aug; 14(8):453. PubMed ID: 24994467
[TBL] [Abstract][Full Text] [Related]
16. Anaphylaxis to chemotherapy and monoclonal antibodies.
Castells MC
Immunol Allergy Clin North Am; 2015 May; 35(2):335-48. PubMed ID: 25841555
[TBL] [Abstract][Full Text] [Related]
17. Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactions.
Picard M; Pur L; Caiado J; Giavina-Bianchi P; Galvão VR; Berlin ST; Campos SM; Matulonis UA; Castells MC
J Allergy Clin Immunol; 2016 Apr; 137(4):1154-1164.e12. PubMed ID: 26725998
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcomes of rapid desensitisation protocols for chemotherapeutic agents and monoclonal antibodies following hypersensitivity reactions.
Kuo JC; Hawkins C; Yip D
Intern Med J; 2014 May; 44(5):442-9. PubMed ID: 24393214
[TBL] [Abstract][Full Text] [Related]
19. Desensitization in delayed drug hypersensitivity reactions -- an EAACI position paper of the Drug Allergy Interest Group.
Scherer K; Brockow K; Aberer W; Gooi JH; Demoly P; Romano A; Schnyder B; Whitaker P; Cernadas JS; Bircher AJ;
Allergy; 2013 Jul; 68(7):844-52. PubMed ID: 23745779
[TBL] [Abstract][Full Text] [Related]
20. Rapid desensitization of hypersensitivity reactions to chemotherapy agents.
Castells M
Curr Drug Saf; 2006 Aug; 1(3):243-51. PubMed ID: 18690934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
